BIOTECH & PHARMA

    Biotech and pharma stocks listed on the ASX.

    Incannex Healthcare NASDAQ IXHL Phase 2 trial IHL-675A treatment rheumatoid arthritis hydroxychloroquine cannabidiol

    Incannex commences phase 2 trial assessing IHL-675A for treatment of rheumatoid arthritis

    StageZero Life Sciences OTC SZLSF oncology protocol cancer treatment biomarker testing

    StageZero Life Sciences launches updated care oncology protocol for enhanced cancer treatment

    Incannex Healthcare NASDAQ IXHL Australia TGA approves psilocybin MDMA treating depression PTSD psychedelics

    Incannex Healthcare to benefit from landmark TGA decision on psychedelics

    Genetic Technologies ASX GTG world-first comprehensive risk assessment test breast ovarian cancer

    Genetic Technologies to launch world-first comprehensive risk assessment test for breast and ovarian cancer

    Incannex Healthcare NASDAQ IXHL files new patent application IHL-42X treat obstructive sleep apnea OSA

    Incannex Healthcare files new patent application for IHL-42X to treat obstructive sleep apnea

    Walgreens NASDAQ WBA VillageMD Summit Health Health-CityMD

    Walgreens-backed VillageMD to buy Summit Health

    Pacific BioSciences of California PacBio NASDAQ PACB DNA sequencing Onso

    Pacific Biosciences announces launch of two new gene-sequencing systems

    UnitedHealth acquisition Change Healthcare NYSE UNH NASDAQ CHNG processing software healthcare insurance

    US judge allows UnitedHealth’s $7.8b acquisition of Change Healthcare to move forward

    Edwards Lifesciences NYSE EW Sapien 3 Ultra Resilia valve heart US FDA approval

    Edwards Lifesciences to release Sapien 3 Ultra Resilia valve in US after gaining FDA approval

    Hoth Therapeutics NASDAQ HOTH HT-004 treatment reduce lung inflammation OVA ovalalbumin

    Hoth Therapeutics’ HT-004 treatment shows potential in reducing lung inflammation

    Bausch + Lomb NYSE BLCO Alfa Instruments global distributor surgical intraocular dyes

    Alfa Instruments chooses Bausch + Lomb as exclusive global distributor for its surgical intraocular dyes

    Pfizer Global Blood Therapeutics NYSE NASDAQ PFE GBT

    Pfizer buys Global Blood Therapeutics for $5.4b

    Incannex Healthcare NASDAQ IXHL 42X obstructive sleep apnea phase 2 clinical trial OSA AHI

    Incannex Healthcare’s IHL-42X lowered apnea hypopnea index score in OSA sufferers during clinical study

    Incannex Healthcare NASDAQ IXHL ASX US Food and Drug Administration FDA IHL-42X treat obstructive sleep apnoea OSA

    Incannex meets with US FDA on development of IHL-42X to treat obstructive sleep apnoea

    Brickell Biotech Inc NASDAQ BBI Botanix Pharmaceuticals ASX BOT medical dermatology axillary hyperhidrosis Sofpironium Bromide gel excessive sweat

    Brickell Biotech sells Sofpironium Bromide asset to Botanix Pharmaceuticals

    Incannex Healthcare NASDAQ IXHL APIRx Pharmaceuticals acquisition medicinal cannabinoid CBD drugs psychedelic

    Incannex Healthcare closes in on completing APIRx Pharmaceuticals acquisition

    Load more
    Small Caps US stock market news penny stocks
    Small Caps is the world's largest financial news platform for information on publicly traded small cap companies.

    Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
    Copyright 2022 Small Caps. All rights reserved.